BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 28892119)

  • 1. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
    Wang Q; Fu J; Hu L; Fang F; Xie L; Chen H; He F; Wu T; Lawrie TA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007289. PubMed ID: 28892119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
    Fu J; Fang F; Xie L; Chen H; He F; Wu T; Hu L; Lawrie TA
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD007289. PubMed ID: 23076934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Hancock BW; Osborne R; Lawrie TA
    Cochrane Database Syst Rev; 2012 Jul; 7(7):CD007102. PubMed ID: 22786502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
    Lawrie TA; Alazzam M; Tidy J; Hancock BW; Osborne R
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD007102. PubMed ID: 27281496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour.
    Deng L; Zhang J; Wu T; Lawrie TA
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD005196. PubMed ID: 23440800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First line chemotherapy in low risk gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Hancock BW; Osborne R
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007102. PubMed ID: 19160319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD008891. PubMed ID: 26760424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment.
    Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H
    Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
    Alazzam M; Tidy J; Osborne R; Coleman R; Hancock BW; Lawrie TA
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008891. PubMed ID: 23235667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.
    Yamamoto E; Trinh TD; Sekiya Y; Tamakoshi K; Nguyen XP; Nishino K; Niimi K; Kotani T; Kajiyama H; Shibata K; Le QT; Kikkawa F
    Nagoya J Med Sci; 2020 May; 82(2):183-191. PubMed ID: 32581399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical assessment of prophylactic chemotherapy in treating with hydatidiform mole: A protocol for systematic review and meta-analysis.
    Xu F; Zheng YL; Lu XY; Qiao HF; Wang Y
    Medicine (Baltimore); 2021 Jun; 100(24):e26341. PubMed ID: 34128882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy for high-risk gestational trophoblastic tumour.
    Deng L; Yan X; Zhang J; Wu T
    Cochrane Database Syst Rev; 2009 Apr; (2):CD005196. PubMed ID: 19370618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole.
    Uberti EM; Diestel MC; GuimarĂ£es FE; De NĂ¡poli G; Schmid H
    Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.
    Lawrie TA; Winter-Roach BA; Heus P; Kitchener HC
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD004706. PubMed ID: 26676202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women.
    Chen H; Xiao L; Li J; Cui L; Huang W
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008018. PubMed ID: 30827035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
    Albright BB; Shorter JM; Mastroyannis SA; Ko EM; Schreiber CA; Sonalkar S
    Obstet Gynecol; 2020 Jan; 135(1):12-23. PubMed ID: 31809433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
    Descargues P; Hajri T; Massardier J; Lotz JP; Devouassoux-Shisheboran M; Allias Montmayeur F; You B; Golfier F; Bolze PA
    Am J Obstet Gynecol; 2021 Oct; 225(4):401.e1-401.e9. PubMed ID: 34019886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy for high-risk gestational trophoblastic tumour.
    Xue Y; Zhang J; Wu TX; An RF
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005196. PubMed ID: 16856085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatments and outcomes in high-risk gestational trophoblastic neoplasia: A systematic review and meta-analysis.
    Albright BB; Ellett T; Knochenhauer HE; Goins EC; Monuszko KA; Kaplan SJ; Previs RA; Moss HA; Havrilesky LJ; Davidson BA
    BJOG; 2023 Apr; 130(5):443-453. PubMed ID: 36648416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.